Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
13,253
archived clinical trials in
Arthritis

Efficacy and Safety of FLOSEAL for Hemostasis in Total Knee Arthroplasty
A Prospective, Randomized, Controlled, Single-Blinded, Multicenter Study to Evaluate the Efficacy and Safety of FLOSEAL for Hemostasis in Primary Unilateral Total Knee Arthroplasty (TKA)
Status: Enrolling
Updated:  7/19/2012
mi
from
Egg Harbor Township, NJ
Efficacy and Safety of FLOSEAL for Hemostasis in Total Knee Arthroplasty
A Prospective, Randomized, Controlled, Single-Blinded, Multicenter Study to Evaluate the Efficacy and Safety of FLOSEAL for Hemostasis in Primary Unilateral Total Knee Arthroplasty (TKA)
Status: Enrolling
Updated: 7/19/2012
Rothman Institute
mi
from
Egg Harbor Township, NJ
Click here to add this to my saved trials
Efficacy and Safety of FLOSEAL for Hemostasis in Total Knee Arthroplasty
A Prospective, Randomized, Controlled, Single-Blinded, Multicenter Study to Evaluate the Efficacy and Safety of FLOSEAL for Hemostasis in Primary Unilateral Total Knee Arthroplasty (TKA)
Status: Enrolling
Updated:  7/19/2012
mi
from
Princeton, NJ
Efficacy and Safety of FLOSEAL for Hemostasis in Total Knee Arthroplasty
A Prospective, Randomized, Controlled, Single-Blinded, Multicenter Study to Evaluate the Efficacy and Safety of FLOSEAL for Hemostasis in Primary Unilateral Total Knee Arthroplasty (TKA)
Status: Enrolling
Updated: 7/19/2012
Princeton Orthopedic Associates
mi
from
Princeton, NJ
Click here to add this to my saved trials
Efficacy and Safety of FLOSEAL for Hemostasis in Total Knee Arthroplasty
A Prospective, Randomized, Controlled, Single-Blinded, Multicenter Study to Evaluate the Efficacy and Safety of FLOSEAL for Hemostasis in Primary Unilateral Total Knee Arthroplasty (TKA)
Status: Enrolling
Updated:  7/19/2012
mi
from
Wilmington, NC
Efficacy and Safety of FLOSEAL for Hemostasis in Total Knee Arthroplasty
A Prospective, Randomized, Controlled, Single-Blinded, Multicenter Study to Evaluate the Efficacy and Safety of FLOSEAL for Hemostasis in Primary Unilateral Total Knee Arthroplasty (TKA)
Status: Enrolling
Updated: 7/19/2012
PGM Research
mi
from
Wilmington, NC
Click here to add this to my saved trials
Efficacy and Safety of FLOSEAL for Hemostasis in Total Knee Arthroplasty
A Prospective, Randomized, Controlled, Single-Blinded, Multicenter Study to Evaluate the Efficacy and Safety of FLOSEAL for Hemostasis in Primary Unilateral Total Knee Arthroplasty (TKA)
Status: Enrolling
Updated:  7/19/2012
mi
from
Philadelphia, PA
Efficacy and Safety of FLOSEAL for Hemostasis in Total Knee Arthroplasty
A Prospective, Randomized, Controlled, Single-Blinded, Multicenter Study to Evaluate the Efficacy and Safety of FLOSEAL for Hemostasis in Primary Unilateral Total Knee Arthroplasty (TKA)
Status: Enrolling
Updated: 7/19/2012
Rothman Institute
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Efficacy and Safety of FLOSEAL for Hemostasis in Total Knee Arthroplasty
A Prospective, Randomized, Controlled, Single-Blinded, Multicenter Study to Evaluate the Efficacy and Safety of FLOSEAL for Hemostasis in Primary Unilateral Total Knee Arthroplasty (TKA)
Status: Enrolling
Updated:  7/19/2012
mi
from
Philadelphia, PA
Efficacy and Safety of FLOSEAL for Hemostasis in Total Knee Arthroplasty
A Prospective, Randomized, Controlled, Single-Blinded, Multicenter Study to Evaluate the Efficacy and Safety of FLOSEAL for Hemostasis in Primary Unilateral Total Knee Arthroplasty (TKA)
Status: Enrolling
Updated: 7/19/2012
Hospital of the University of Pennsylvania, Dept. of Orthopedics
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Efficacy and Safety of FLOSEAL for Hemostasis in Total Knee Arthroplasty
A Prospective, Randomized, Controlled, Single-Blinded, Multicenter Study to Evaluate the Efficacy and Safety of FLOSEAL for Hemostasis in Primary Unilateral Total Knee Arthroplasty (TKA)
Status: Enrolling
Updated:  7/19/2012
mi
from
Philadelphia, PA
Efficacy and Safety of FLOSEAL for Hemostasis in Total Knee Arthroplasty
A Prospective, Randomized, Controlled, Single-Blinded, Multicenter Study to Evaluate the Efficacy and Safety of FLOSEAL for Hemostasis in Primary Unilateral Total Knee Arthroplasty (TKA)
Status: Enrolling
Updated: 7/19/2012
Temple University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Efficacy and Safety of FLOSEAL for Hemostasis in Total Knee Arthroplasty
A Prospective, Randomized, Controlled, Single-Blinded, Multicenter Study to Evaluate the Efficacy and Safety of FLOSEAL for Hemostasis in Primary Unilateral Total Knee Arthroplasty (TKA)
Status: Enrolling
Updated:  7/19/2012
mi
from
Philadelphia, PA
Efficacy and Safety of FLOSEAL for Hemostasis in Total Knee Arthroplasty
A Prospective, Randomized, Controlled, Single-Blinded, Multicenter Study to Evaluate the Efficacy and Safety of FLOSEAL for Hemostasis in Primary Unilateral Total Knee Arthroplasty (TKA)
Status: Enrolling
Updated: 7/19/2012
Jefferson Medical College, The Rothman Institute
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Draining PLN and Synovial Inflammation in RA Knee Joints Pre and Post Anti-TNF or B Cell Depletion Therapy
The Morphologic and Functional Relationship Between the Draining PLN and Synovial Inflammation in the Knee Joints of RA Patients Before and After Anti-TNF or B Cell Depletion Therapy
Status: Enrolling
Updated:  7/27/2012
mi
from
Rochester, NY
Draining PLN and Synovial Inflammation in RA Knee Joints Pre and Post Anti-TNF or B Cell Depletion Therapy
The Morphologic and Functional Relationship Between the Draining PLN and Synovial Inflammation in the Knee Joints of RA Patients Before and After Anti-TNF or B Cell Depletion Therapy
Status: Enrolling
Updated: 7/27/2012
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
Prediction of Response to Intra-articular Injections of Hyaluronic Acid for Knee Osteoarthritis
Prediction of Response to Intra-articular Injections of Hyaluronic Acid for Knee Osteoarthritis
Status: Enrolling
Updated:  8/1/2012
mi
from
Detroit, MI
Prediction of Response to Intra-articular Injections of Hyaluronic Acid for Knee Osteoarthritis
Prediction of Response to Intra-articular Injections of Hyaluronic Acid for Knee Osteoarthritis
Status: Enrolling
Updated: 8/1/2012
Henry Ford Medical Center
mi
from
Detroit, MI
Click here to add this to my saved trials
Prediction of Response to Intra-articular Injections of Hyaluronic Acid for Knee Osteoarthritis
Prediction of Response to Intra-articular Injections of Hyaluronic Acid for Knee Osteoarthritis
Status: Enrolling
Updated:  8/1/2012
mi
from
Portsmouth, VA
Prediction of Response to Intra-articular Injections of Hyaluronic Acid for Knee Osteoarthritis
Prediction of Response to Intra-articular Injections of Hyaluronic Acid for Knee Osteoarthritis
Status: Enrolling
Updated: 8/1/2012
Naval Medical Center Portsmouth (this site can only enroll patients who are eligible to be treated at a military facility)
mi
from
Portsmouth, VA
Click here to add this to my saved trials
Patient and Provider Interventions for Managing Osteoarthritis in Primary Care
Patient and Provider Interventions for Managing Osteoarthritis in Primary Care
Status: Enrolling
Updated:  8/10/2012
mi
from
Durham, NC
Patient and Provider Interventions for Managing Osteoarthritis in Primary Care
Patient and Provider Interventions for Managing Osteoarthritis in Primary Care
Status: Enrolling
Updated: 8/10/2012
Durham VA Medical Center
mi
from
Durham, NC
Click here to add this to my saved trials
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated:  8/23/2012
mi
from
San Diego, CA
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated: 8/23/2012
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated:  8/23/2012
mi
from
Denver, CO
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated: 8/23/2012
Clinical Research Facility
mi
from
Denver, CO
Click here to add this to my saved trials
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated:  8/23/2012
mi
from
Newark, DE
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated: 8/23/2012
Clinical Research Facility
mi
from
Newark, DE
Click here to add this to my saved trials
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated:  8/23/2012
mi
from
Fort Lauderdale, FL
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated: 8/23/2012
Clinical Research Facility
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated:  8/23/2012
mi
from
Evanston, IL
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated: 8/23/2012
Clinical Research Facility
mi
from
Evanston, IL
Click here to add this to my saved trials
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated:  8/23/2012
mi
from
Baltimore, MD
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated: 8/23/2012
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated:  8/23/2012
mi
from
Ayer, MA
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated: 8/23/2012
Clinical Research Facility
mi
from
Ayer, MA
Click here to add this to my saved trials
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated:  8/23/2012
mi
from
Henderson, NV
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated: 8/23/2012
Clinical Research Facility
mi
from
Henderson, NV
Click here to add this to my saved trials
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated:  8/23/2012
mi
from
Teaneck, NJ
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated: 8/23/2012
Clinical Research Facility
mi
from
Teaneck, NJ
Click here to add this to my saved trials
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated:  8/23/2012
mi
from
Bronx, NY
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated: 8/23/2012
Clinical Research Facility
mi
from
Bronx, NY
Click here to add this to my saved trials
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated:  8/23/2012
mi
from
Asheville, NC
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated: 8/23/2012
Clinical Research Facility
mi
from
Asheville, NC
Click here to add this to my saved trials
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated:  8/23/2012
mi
from
Akron, OH
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated: 8/23/2012
Clinical Research Facility
mi
from
Akron, OH
Click here to add this to my saved trials
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated:  8/23/2012
mi
from
Oklahoma City, OK
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated: 8/23/2012
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated:  8/23/2012
mi
from
Allentown, PA
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated: 8/23/2012
Clinical Research Facility
mi
from
Allentown, PA
Click here to add this to my saved trials
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated:  8/23/2012
mi
from
Anderson, SC
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated: 8/23/2012
Clinical Research Facility
mi
from
Anderson, SC
Click here to add this to my saved trials
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated:  8/23/2012
mi
from
Houston, TX
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated: 8/23/2012
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated:  8/23/2012
mi
from
Annandale, VA
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated: 8/23/2012
Clinical Research Facility
mi
from
Annandale, VA
Click here to add this to my saved trials
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated:  8/23/2012
mi
from
Bellingham, WA
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated: 8/23/2012
Clinical Research Facility
mi
from
Bellingham, WA
Click here to add this to my saved trials
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated:  8/23/2012
mi
from
Beloit, WI
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated: 8/23/2012
Clinical Research Facility
mi
from
Beloit, WI
Click here to add this to my saved trials
Impact Of RA Therapy Compliance On Patient-Reported Outcomes
Impact Of RA Therapy Compliance On Patient-Reported Outcomes
Status: Enrolling
Updated:  9/4/2012
mi
from
Boston, MA
Impact Of RA Therapy Compliance On Patient-Reported Outcomes
Impact Of RA Therapy Compliance On Patient-Reported Outcomes
Status: Enrolling
Updated: 9/4/2012
Pfizer Investigational Site
mi
from
Boston, MA
Click here to add this to my saved trials
Gait Analysis of Anterior Versus Posterior Approach in Performance of Total Hip Arthroplasty
Gait Analysis of Anterior vs. Posterior Approach in Performance of Total Hip Arthroplasty: A Multi-Centre, Prospective Trial
Status: Enrolling
Updated:  9/5/2012
mi
from
Surprise, AZ
Gait Analysis of Anterior Versus Posterior Approach in Performance of Total Hip Arthroplasty
Gait Analysis of Anterior vs. Posterior Approach in Performance of Total Hip Arthroplasty: A Multi-Centre, Prospective Trial
Status: Enrolling
Updated: 9/5/2012
Sun Valley Orthopedic Surgeons
mi
from
Surprise, AZ
Click here to add this to my saved trials
Gait Analysis of Anterior Versus Posterior Approach in Performance of Total Hip Arthroplasty
Gait Analysis of Anterior vs. Posterior Approach in Performance of Total Hip Arthroplasty: A Multi-Centre, Prospective Trial
Status: Enrolling
Updated:  9/5/2012
mi
from
Fresno, CA
Gait Analysis of Anterior Versus Posterior Approach in Performance of Total Hip Arthroplasty
Gait Analysis of Anterior vs. Posterior Approach in Performance of Total Hip Arthroplasty: A Multi-Centre, Prospective Trial
Status: Enrolling
Updated: 9/5/2012
D. Kevin Lester, MD
mi
from
Fresno, CA
Click here to add this to my saved trials
Gait Analysis of Anterior Versus Posterior Approach in Performance of Total Hip Arthroplasty
Gait Analysis of Anterior vs. Posterior Approach in Performance of Total Hip Arthroplasty: A Multi-Centre, Prospective Trial
Status: Enrolling
Updated:  9/5/2012
mi
from
Lone Tree, CO
Gait Analysis of Anterior Versus Posterior Approach in Performance of Total Hip Arthroplasty
Gait Analysis of Anterior vs. Posterior Approach in Performance of Total Hip Arthroplasty: A Multi-Centre, Prospective Trial
Status: Enrolling
Updated: 9/5/2012
Peak Orthopedics
mi
from
Lone Tree, CO
Click here to add this to my saved trials
Gait Analysis of Anterior Versus Posterior Approach in Performance of Total Hip Arthroplasty
Gait Analysis of Anterior vs. Posterior Approach in Performance of Total Hip Arthroplasty: A Multi-Centre, Prospective Trial
Status: Enrolling
Updated:  9/5/2012
mi
from
St. George, UT
Gait Analysis of Anterior Versus Posterior Approach in Performance of Total Hip Arthroplasty
Gait Analysis of Anterior vs. Posterior Approach in Performance of Total Hip Arthroplasty: A Multi-Centre, Prospective Trial
Status: Enrolling
Updated: 9/5/2012
Intermountain Healthcare
mi
from
St. George, UT
Click here to add this to my saved trials
Study to Assess the Safety and Tolerability of MEDI5117 in Rheumatoid Arthritis Patients
A Double-blind, Placebo-controlled, Randomized Study in Rheumatoid Arthritis Subjects to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Doses of MEDI5117 (Anti-IL-6)
Status: Enrolling
Updated:  9/10/2012
mi
from
Kansas City, KA
Study to Assess the Safety and Tolerability of MEDI5117 in Rheumatoid Arthritis Patients
A Double-blind, Placebo-controlled, Randomized Study in Rheumatoid Arthritis Subjects to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Doses of MEDI5117 (Anti-IL-6)
Status: Enrolling
Updated: 9/10/2012
Clinical Research Facility
mi
from
Kansas City, KA
Click here to add this to my saved trials
Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis
OSKIRA-ABPM: A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of Fostamatinib 100 mg Twice Daily on 24-hour Ambulatory Blood Pressure in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  9/14/2012
mi
from
Birmingham, AL
Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis
OSKIRA-ABPM: A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of Fostamatinib 100 mg Twice Daily on 24-hour Ambulatory Blood Pressure in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 9/14/2012
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis
OSKIRA-ABPM: A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of Fostamatinib 100 mg Twice Daily on 24-hour Ambulatory Blood Pressure in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  9/14/2012
mi
from
San Diego, CA
Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis
OSKIRA-ABPM: A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of Fostamatinib 100 mg Twice Daily on 24-hour Ambulatory Blood Pressure in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 9/14/2012
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis
OSKIRA-ABPM: A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of Fostamatinib 100 mg Twice Daily on 24-hour Ambulatory Blood Pressure in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  9/14/2012
mi
from
New Haven, CT
Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis
OSKIRA-ABPM: A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of Fostamatinib 100 mg Twice Daily on 24-hour Ambulatory Blood Pressure in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 9/14/2012
Clinical Research Facility
mi
from
New Haven, CT
Click here to add this to my saved trials
Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis
OSKIRA-ABPM: A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of Fostamatinib 100 mg Twice Daily on 24-hour Ambulatory Blood Pressure in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  9/14/2012
mi
from
Fort Lauderdale, FL
Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis
OSKIRA-ABPM: A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of Fostamatinib 100 mg Twice Daily on 24-hour Ambulatory Blood Pressure in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 9/14/2012
Clinical Research Facility
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis
OSKIRA-ABPM: A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of Fostamatinib 100 mg Twice Daily on 24-hour Ambulatory Blood Pressure in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  9/14/2012
mi
from
Atlanta, GA
Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis
OSKIRA-ABPM: A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of Fostamatinib 100 mg Twice Daily on 24-hour Ambulatory Blood Pressure in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 9/14/2012
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis
OSKIRA-ABPM: A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of Fostamatinib 100 mg Twice Daily on 24-hour Ambulatory Blood Pressure in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  9/14/2012
mi
from
Anderson, IN
Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis
OSKIRA-ABPM: A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of Fostamatinib 100 mg Twice Daily on 24-hour Ambulatory Blood Pressure in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 9/14/2012
Clinical Research Facility
mi
from
Anderson, IN
Click here to add this to my saved trials
Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis
OSKIRA-ABPM: A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of Fostamatinib 100 mg Twice Daily on 24-hour Ambulatory Blood Pressure in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  9/14/2012
mi
from
Baltimore, MD
Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis
OSKIRA-ABPM: A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of Fostamatinib 100 mg Twice Daily on 24-hour Ambulatory Blood Pressure in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 9/14/2012
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis
OSKIRA-ABPM: A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of Fostamatinib 100 mg Twice Daily on 24-hour Ambulatory Blood Pressure in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  9/14/2012
mi
from
St Louis, MO
Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis
OSKIRA-ABPM: A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of Fostamatinib 100 mg Twice Daily on 24-hour Ambulatory Blood Pressure in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 9/14/2012
Clinical Research Facility
mi
from
St Louis, MO
Click here to add this to my saved trials
Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis
OSKIRA-ABPM: A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of Fostamatinib 100 mg Twice Daily on 24-hour Ambulatory Blood Pressure in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  9/14/2012
mi
from
Teaneck, NJ
Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis
OSKIRA-ABPM: A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of Fostamatinib 100 mg Twice Daily on 24-hour Ambulatory Blood Pressure in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 9/14/2012
Clinical Research Facility
mi
from
Teaneck, NJ
Click here to add this to my saved trials
Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis
OSKIRA-ABPM: A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of Fostamatinib 100 mg Twice Daily on 24-hour Ambulatory Blood Pressure in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  9/14/2012
mi
from
Albuquerque, NM
Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis
OSKIRA-ABPM: A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of Fostamatinib 100 mg Twice Daily on 24-hour Ambulatory Blood Pressure in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 9/14/2012
Clinical Research Facility
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis
OSKIRA-ABPM: A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of Fostamatinib 100 mg Twice Daily on 24-hour Ambulatory Blood Pressure in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  9/14/2012
mi
from
Bronx, NY
Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis
OSKIRA-ABPM: A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of Fostamatinib 100 mg Twice Daily on 24-hour Ambulatory Blood Pressure in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 9/14/2012
Clinical Research Facility
mi
from
Bronx, NY
Click here to add this to my saved trials
Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis
OSKIRA-ABPM: A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of Fostamatinib 100 mg Twice Daily on 24-hour Ambulatory Blood Pressure in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  9/14/2012
mi
from
Asheville, NC
Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis
OSKIRA-ABPM: A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of Fostamatinib 100 mg Twice Daily on 24-hour Ambulatory Blood Pressure in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 9/14/2012
Clinical Research Facility
mi
from
Asheville, NC
Click here to add this to my saved trials
Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis
OSKIRA-ABPM: A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of Fostamatinib 100 mg Twice Daily on 24-hour Ambulatory Blood Pressure in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  9/14/2012
mi
from
Akron, OH
Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis
OSKIRA-ABPM: A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of Fostamatinib 100 mg Twice Daily on 24-hour Ambulatory Blood Pressure in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 9/14/2012
Clinical Research Facility
mi
from
Akron, OH
Click here to add this to my saved trials
Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis
OSKIRA-ABPM: A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of Fostamatinib 100 mg Twice Daily on 24-hour Ambulatory Blood Pressure in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  9/14/2012
mi
from
Bend, OR
Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis
OSKIRA-ABPM: A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of Fostamatinib 100 mg Twice Daily on 24-hour Ambulatory Blood Pressure in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 9/14/2012
Clinical Research Facility
mi
from
Bend, OR
Click here to add this to my saved trials